Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status
The Bcl-2 family of proteins is critical to the life and death of malignant B-lymphocytes. Interfering with their activity using small-molecule inhibitors (SMI) is being explored as a new therapeutic strategy ...
Citation: Journal of Hematology & Oncology 2009 2:8